Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.

Biotech Health services Manufacturing

United Kingdom

France

Israel

United States

Investments

07 June 2025

Share:

Draig Therapeutics (company)

United Kingdom

Biotech Health services Manufacturing

Total investments received (USD): 142.95m

Round value (USD): 142.95m

Round investors: Sanofi Ventures Schroders Canaan Partners Intermediate Capital Group SV Health Investors SR One Access Biotechnology

Company: Draig Therapeutics

Industry: Biotech Health services Manufacturing

Related deals

Dark Blue Therapeutics was acquired for $840 million by Amgen in the USA

Biotech Manufacturing

United Kingdom

United States

Secondary 06 December 2025

Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.

Health services Manufacturing Pharma

United Kingdom

France

Sweden

United States

Netherlands

Switzerland

Investments 07 November 2025

Vicebio was acquired by Sanofi for $1.6B

Biotech Health services

United Kingdom

France

Secondary 14 July 2025

OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion

Health services Manufacturing

United Kingdom

Japan

Secondary 14 July 2025

CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.

Biotech Health services Manufacturing

United Kingdom

Netherlands

United States

Investments 09 May 2025